<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The presence of Epstein-Barr virus (EBV) DNA and antigens was assessed by polymerase chain reaction and immunohistology, respectively, in a total of 92 cases of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e>, angioimmunoblastic <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo>, CD30-positive anaplastic large cell (ALC) <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-associated atypical lymphoproliferations (ALP) </plain></SENT>
<SENT sid="1" pm="."><plain>Proportions of the EBV DNA-positive lesions showed latent membrane protein (LMP) expression; some of the LMP-positive ALC <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and ALP cases also displayed EBNA2 immunostaining </plain></SENT>
<SENT sid="2" pm="."><plain>BZLF1-protein and gp250/350 immunoreactivity were absent in <z:hpo ids='HP_0000001'>all</z:hpo> instances indicating latent <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Since the LMP gene has transforming potential, our findings support the concept of a pathoetiological role for EBV in these lymphoproliferative lesions </plain></SENT>
</text></document>